BSX
Price
$95.12
Change
-$0.13 (-0.14%)
Updated
Apr 17 closing price
Capitalization
100.1B
4 days until earnings call
IQV
Price
$143.91
Change
-$4.53 (-3.05%)
Updated
Apr 17 closing price
Capitalization
45.3B
11 days until earnings call
Ad is loading...

BSX vs IQV

Header iconBSX vs IQV Comparison
Open Charts BSX vs IQVBanner chart's image
Boston Scientific
Price$95.12
Change-$0.13 (-0.14%)
Volume$6.67M
Capitalization100.1B
IQVIA Holdings
Price$143.91
Change-$4.53 (-3.05%)
Volume$3.3M
Capitalization45.3B
BSX vs IQV Comparison Chart
Loading...
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IQV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BSX vs. IQV commentary
Apr 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSX is a Hold and IQV is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 19, 2025
Stock price -- (BSX: $95.12 vs. IQV: $143.91)
Brand notoriety: BSX and IQV are both notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BSX: 76% vs. IQV: 180%
Market capitalization -- BSX: $100.1B vs. IQV: $45.3B
BSX [@Medical Specialties] is valued at $100.1B. IQV’s [@Medical Specialties] market capitalization is $45.3B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BSX’s FA Score shows that 2 FA rating(s) are green whileIQV’s FA Score has 0 green FA rating(s).

  • BSX’s FA Score: 2 green, 3 red.
  • IQV’s FA Score: 0 green, 5 red.
According to our system of comparison, BSX is a better buy in the long-term than IQV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BSX’s TA Score shows that 4 TA indicator(s) are bullish while IQV’s TA Score has 4 bullish TA indicator(s).

  • BSX’s TA Score: 4 bullish, 6 bearish.
  • IQV’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both BSX and IQV are a good buy in the short-term.

Price Growth

BSX (@Medical Specialties) experienced а +2.68% price change this week, while IQV (@Medical Specialties) price change was +0.48% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.59%. For the same industry, the average monthly price growth was -9.77%, and the average quarterly price growth was -5.36%.

Reported Earning Dates

BSX is expected to report earnings on Jul 23, 2025.

IQV is expected to report earnings on Jul 29, 2025.

Industries' Descriptions

@Medical Specialties (+1.59% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BSX($100B) has a higher market cap than IQV($45.3B). BSX has higher P/E ratio than IQV: BSX (63.64) vs IQV (34.14). BSX YTD gains are higher at: 6.494 vs. IQV (-26.767). BSX has higher annual earnings (EBITDA): 3.45B vs. IQV (3.26B). IQV has more cash in the bank: 1.5B vs. BSX (865M). BSX has less debt than IQV: BSX (9.49B) vs IQV (13.9B). IQV has higher revenues than BSX: IQV (15B) vs BSX (14.2B).
BSXIQVBSX / IQV
Capitalization100B45.3B221%
EBITDA3.45B3.26B106%
Gain YTD6.494-26.767-24%
P/E Ratio63.6434.14186%
Revenue14.2B15B95%
Total Cash865M1.5B58%
Total Debt9.49B13.9B68%
FUNDAMENTALS RATINGS
BSX vs IQV: Fundamental Ratings
BSX
IQV
OUTLOOK RATING
1..100
7559
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
69
Overvalued
PROFIT vs RISK RATING
1..100
368
SMR RATING
1..100
7341
PRICE GROWTH RATING
1..100
4665
P/E GROWTH RATING
1..100
2786
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IQV's Valuation (69) in the Servicestothe Health Industry industry is in the same range as BSX (83) in the Medical Specialties industry. This means that IQV’s stock grew similarly to BSX’s over the last 12 months.

BSX's Profit vs Risk Rating (3) in the Medical Specialties industry is somewhat better than the same rating for IQV (68) in the Servicestothe Health Industry industry. This means that BSX’s stock grew somewhat faster than IQV’s over the last 12 months.

IQV's SMR Rating (41) in the Servicestothe Health Industry industry is in the same range as BSX (73) in the Medical Specialties industry. This means that IQV’s stock grew similarly to BSX’s over the last 12 months.

BSX's Price Growth Rating (46) in the Medical Specialties industry is in the same range as IQV (65) in the Servicestothe Health Industry industry. This means that BSX’s stock grew similarly to IQV’s over the last 12 months.

BSX's P/E Growth Rating (27) in the Medical Specialties industry is somewhat better than the same rating for IQV (86) in the Servicestothe Health Industry industry. This means that BSX’s stock grew somewhat faster than IQV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BSXIQV
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
67%
Momentum
ODDS (%)
Bearish Trend 2 days ago
45%
Bearish Trend 2 days ago
59%
MACD
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
64%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
46%
Bearish Trend 2 days ago
64%
Advances
ODDS (%)
Bullish Trend 5 days ago
62%
Bullish Trend 5 days ago
62%
Declines
ODDS (%)
Bearish Trend 15 days ago
45%
Bearish Trend 2 days ago
60%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
65%
Aroon
ODDS (%)
Bearish Trend 2 days ago
45%
Bearish Trend 2 days ago
64%
View a ticker or compare two or three
Ad is loading...
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IQV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SNDR22.480.76
+3.50%
Schneider National
BLFY8.910.08
+0.91%
Blue Foundry Bancorp
WTW321.00-3.73
-1.15%
Willis Towers Watson Public Limited
CMMB1.12-0.04
-3.45%
Chemomab Therapeutics Ltd
CCEC17.00-1.43
-7.75%
Capital Clean Energy Carriers Corp

BSX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BSX has been closely correlated with ISRG. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if BSX jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSX
1D Price
Change %
BSX100%
-0.14%
ISRG - BSX
72%
Closely correlated
+0.29%
SYK - BSX
66%
Loosely correlated
-0.05%
MMSI - BSX
62%
Loosely correlated
+0.35%
AORT - BSX
48%
Loosely correlated
-0.65%
IQV - BSX
45%
Loosely correlated
-3.05%
More

IQV and

Correlation & Price change

A.I.dvisor indicates that over the last year, IQV has been closely correlated with CRL. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if IQV jumps, then CRL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IQV
1D Price
Change %
IQV100%
-3.05%
CRL - IQV
72%
Closely correlated
+1.73%
ICLR - IQV
69%
Closely correlated
-2.94%
TMO - IQV
67%
Closely correlated
-2.13%
RVTY - IQV
66%
Closely correlated
-1.99%
A - IQV
66%
Closely correlated
-0.21%
More